Dangerous Health Fraud in Corporate America Series
In the summer of 2005, Bausch & Lomb learned of serious eye infections caused by their ReNu with MoistureLoc contact lens solution. Approximately 6 months later they initiated recalls only in Hong Kong and Malaysia, continuing to sell the product in the U.S. until April 2006, completely disregarding the safety of U.S. consumers. Evidence later showed that they: cut corners in the design and testing of ReNu; lied to the FDA to gain their approval; switched the formulation of ReNu to get it to market quicker; and hid its February 2006 recall in Asia from U.S. regulatory agencies. As a result thousands of people were injured, including Elizabeth Poole who underwent painful and extensive surgeries and treatments, eventually losing her eye. This is her story and the story of how a major Fortune 500 company lied to the FDA and consumers all in the name of profit. Ken Wexler and Ed Wallace, partners at the law firm of Wexler Wallace LLP, join Elizabeth Poole and Debra Pritss, a registered nurse with Wexler Wallace LLP, to discuss this case and its impact on consumers.
You can contact Ken Wexler and Ed Wallace at 312-346-2222,
